{"id":"CHEMBL100239","canonicalSmiles":"Nc1nc(N)c2c(Sc3ccccc3)cccc2n1","inchiKey":"BUFDQCGCADQQQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TCMDC-131943","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-131943"],"crossReferences":{"drugbank":["DB04163"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076211","canonicalSmiles":"Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1","inchiKey":"FSKFPVLPFLJRQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLPERISONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mydeton","N-553 FREE BASE","N-553 [AS HYDROCHLORIDE]","NSC-107321","Tolperisone","Tolperisone hydrochloride"],"crossReferences":{"Wikipedia":["Tolperisone"],"drugbank":["DB06264"]},"childChemblIds":["CHEMBL2107740","CHEMBL1395150"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL115357","canonicalSmiles":"CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NNC(=O)NNC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1","inchiKey":"HGDUWJVGIGLVOH-ZEQRLZLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL115357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL115824","canonicalSmiles":"Nc1ccnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"NVUDDRWKCUAERS-PNHWDRBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1-Deaza-Adenosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Deaza-Adenosine"],"crossReferences":{"PubChem":["26756663"],"drugbank":["DB04218"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1186579","canonicalSmiles":"C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5","inchiKey":"JVLBPIPGETUEET-GAAHOAFPSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLNALTREXONE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MRZ-2663","Methylnaltrexone"],"crossReferences":{"DailyMed":["methylnaltrexone%20bromide"],"Wikipedia":["Methylnaltrexone"]},"childChemblIds":["CHEMBL470617","CHEMBL1201770"],"count":6,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003086","MONDO_0004880","EFO_0010282","EFO_0008585","EFO_0001645","HP_0001410","MONDO_0004567","EFO_1000948","EFO_0005611","MONDO_0004565","HP_0002019"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 6 investigational indications."}
{"id":"CHEMBL118865","canonicalSmiles":"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCC2(CCCO2)CC1N1CCCC1","inchiKey":"NYKCGQQJNVPOLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPIRADOLINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Spiradoline"],"childChemblIds":["CHEMBL2218921"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1190476","canonicalSmiles":"C[N+](C)(C)c1ccc(CNC(=O)c2cc3cc(OCc4ccccc4)ccc3n2Cc2cccc(C(=N)N)c2)cc1","inchiKey":"UFKJQTGPBFWMGT-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1190476","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02269"]},"childChemblIds":["CHEMBL540898"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198138","canonicalSmiles":"N=C(N)c1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CCC2CCCCC2)cc1","inchiKey":"DOTBZTLJSXFKCP-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07131"]},"childChemblIds":["CHEMBL596999"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198855","canonicalSmiles":"CC(C)(CC1Cc2ccccc2C1)NC[C@@H](O)COc1cc(CCC(=O)O)cc(F)c1F","inchiKey":"FQJISUPNMFRIFZ-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONACALERET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ronacaleret","Sb-751689"],"crossReferences":{"drugbank":["DB05255"]},"childChemblIds":["CHEMBL1083998"],"count":2,"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_0003931","EFO_0003882"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200","canonicalSmiles":"CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N","inchiKey":"CMHHMUWAYWTMGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENOXINATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benoxinate","Oxybuprocaine"],"crossReferences":{"DailyMed":["benoxinate%20hydrochloride"],"PubChem":["11112575","56320722"],"Wikipedia":["Oxybuprocaine"],"drugbank":["DB00892"],"chEBI":["309594"]},"childChemblIds":["CHEMBL1200654"],"count":1,"approvedIndications":["HP_0000989"],"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["HP_0000989"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for pruritus."}
{"id":"CHEMBL1200343","canonicalSmiles":"CC(C)(C)N.CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC","inchiKey":"IYNMDWMQHSMDDE-MHXJNQAMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERINDOPRIL ERBUMINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1581","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aceon","Coversyl","Perindopril erbumine"],"synonyms":["MCN-A-2833-109","Perindopril erbumine","Perindopril tert-butylamine","S-9490-3"],"crossReferences":{"DailyMed":["perindopril%20erbumine"],"chEBI":["8025"]},"count":2,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_1002032","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for hypertension and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200621","canonicalSmiles":"CO/N=C1\\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN.CS(=O)(=O)O","inchiKey":"JIYMVSQRGZEYAX-CWUUNJJBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GEMIFLOXACIN MESYLATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL430","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Factive","Gemifloxacin mesylate"],"synonyms":["Gemifloxacin mesilate","Gemifloxacin mesylate","Gemifloxacin methanesulfonate","LB 20304A","LB-20304A","SB-265805-S"],"crossReferences":{"DailyMed":["gemifloxacin%20mesylate"],"PubChem":["144205026","170465333","26749070"],"chEBI":["53749"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200763","canonicalSmiles":"O=C([O-])CNC(=O)c1ccccc1[131I].[Na+]","inchiKey":"XYITYKDGJLHYPW-UDYUCQKZSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOHIPPURATE SODIUM I 131","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1681","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hippuran i 131","Hippuran-131","Hipputope","Iodohippurate sodium i 131"],"synonyms":["Iodohippurate sodium i 131","Iodohippurate sodium i-131","Sodium Iodohippurate (131I)","Sodium iodohippurate (131i)","Sodium iodohippurate (131i) injection"],"crossReferences":{"drugbank":["DB09382"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201002","canonicalSmiles":"CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl","inchiKey":"FYBXRCFPOTXTJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARTEOLOL HYDROCHLORIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL839","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carteolol hydrochloride","Cartrol","Ocupress","Teoptic"],"synonyms":["ABBOTT-43326","Carteolol hydrochloride","OPC-1085"],"crossReferences":{"DailyMed":["carteolol%20hydrochloride"],"PubChem":["144204205","170465122","56463040"],"chEBI":["3438"]},"count":1,"approvedIndications":["EFO_0004190"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0004190"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for open-angle glaucoma."}
{"id":"CHEMBL1201162","canonicalSmiles":"CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21.Cl","inchiKey":"OSRUSFPMRGDLAG-QMGYSKNISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORZOLAMIDE HYDROCHLORIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL218490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cosopt Pf","Dorzolamide hydrochloride","Trusopt"],"synonyms":["Dorzolamide hydrochloride","MK-507"],"crossReferences":{"DailyMed":["dorzolamide%20hydrochloride"],"PubChem":["170465119","56463558"],"chEBI":["4703"]},"count":3,"approvedIndications":["EFO_0004190","EFO_1001069"],"linkedTargets":{"rows":["ENSG00000104267"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for open-angle glaucoma and ocular hypertension and has 1 investigational indication."}
{"id":"CHEMBL1201202","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O","inchiKey":"KANJSNBRCNMZMV-ABRZTLGGSA-N","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"FONDAPARINUX","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fondaparinux"],"crossReferences":{"DailyMed":["fondaparinux%20sodium"],"Wikipedia":["Fondaparinux"],"drugbank":["DB00569"],"chEBI":["61033"]},"childChemblIds":["CHEMBL1200644"],"count":12,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0009686","EFO_0001074","EFO_0001075","EFO_0000275","EFO_0004286","HP_0001873","HP_0001907","HP_0000083","MONDO_0100096","EFO_0003827","EFO_0003907","EFO_0007541","HP_0004419","EFO_0005672","HP_0004936"],"count":16},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for recurrent thrombophlebitis and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201261","canonicalSmiles":"CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)O)c1I","inchiKey":"YMOXVLQZFAUUKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYROPANOIC ACID","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tyropanoate","Tyropanoic Acid","Tyropanoic acid"],"crossReferences":{"Wikipedia":["Tyropanoic_acid"],"drugbank":["DB09340"]},"childChemblIds":["CHEMBL1200899"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL1201286","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1","inchiKey":"GFRUPHOKLBPHTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENONIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxyphenonium"],"crossReferences":{"drugbank":["DB00219"]},"childChemblIds":["CHEMBL1200906"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201821","drugType":"Protein","blackBoxWarning":false,"name":"PALIFERMIN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kepivance"],"synonyms":["Palifermin"],"crossReferences":{"DailyMed":["palifermin"],"DrugCentral":["4804"],"Wikipedia":["Palifermin"]},"count":25,"linkedTargets":{"rows":["ENSG00000066468"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0013730","EFO_0006859","EFO_0000222","EFO_0005952","MONDO_0021063","MONDO_0044881","EFO_0004599","EFO_0005555","EFO_0000565","EFO_0003885","MONDO_0015760","Orphanet_79364","EFO_0009688","MONDO_0021193","EFO_0000764","EFO_1001898","EFO_0000270","EFO_0006475","EFO_0000574","EFO_0001378","EFO_0000183","EFO_0000707","EFO_0004276","EFO_1001451","EFO_1001904"],"count":26},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 25 investigational indications."}
{"id":"CHEMBL1201864","canonicalSmiles":"C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N","inchiKey":"AZFLJNIPTRTECV-FUMNGEBKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIENOGEST","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Endometrion"],"synonyms":["Dienogest","M 18575","M-18575","MJR-35","STS 557","STS-557","ZK 37659","ZK-37659"],"crossReferences":{"DailyMed":["dienogest"],"Wikipedia":["Dienogest"],"drugbank":["DB09123"],"chEBI":["70708"]},"count":5,"approvedIndications":["HP_0000132"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for menorrhagia and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229789","canonicalSmiles":"O=C(O)c1ccc2nc(-c3c(Cl)cccc3Cl)oc2c1","inchiKey":"XVNRKPCHMYOPPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229789","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06907"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230062","canonicalSmiles":"O=C(O)COc1cc(Cl)ccc1C(=O)NCc1ccc(Br)cc1F","inchiKey":"ZLIGBZRXAQNUFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230062","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07028"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230607","canonicalSmiles":"CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C","inchiKey":"HUXYBQXJVXOMKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHA-793887","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PHA-793887","Pha-793887"],"crossReferences":{"PubChem":["137276012"],"drugbank":["DB12686"]},"count":1,"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000123374","ENSG00000134058","ENSG00000164885","ENSG00000135446","ENSG00000155111","ENSG00000136807","ENSG00000105810","ENSG00000059758","ENSG00000167258","ENSG00000138395","ENSG00000058091","ENSG00000248333","ENSG00000117266","ENSG00000132964","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1231124","canonicalSmiles":"Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1","inchiKey":"PDOQBOJDRPLBQU-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1480","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-1480","AZD1480","Azd 1480","Azd-1480"],"crossReferences":{"drugbank":["DB12588"]},"count":5,"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0002430","MONDO_0001056","EFO_0003060","EFO_0000311","EFO_0000479"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1231806","canonicalSmiles":"Nc1nc2cc3[nH]c(NCCN4CCOCC4)nc3cc2c(=O)[nH]1","inchiKey":"JUHXOBNFTFUPKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231806","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233058","canonicalSmiles":"OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"WQZGKKKJIJFFOK-PHYPRBDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALACTOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galactose"],"crossReferences":{"PubChem":["29215384"],"chEBI":["28061"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1234162","canonicalSmiles":"COCCOCCOC","inchiKey":"SBZXBUIDTXKZTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234162","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209538","144210397"],"drugbank":["DB02935"],"chEBI":["46784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235157","canonicalSmiles":"Oc1c(Br)c(Br)c(Br)c(Br)c1Br","inchiKey":"SVHOVVJFOWGYJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTABROMOPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207537","17389565","56436654"],"drugbank":["DB03167"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235660","canonicalSmiles":"O=C(Cc1cccs1)N1CCC(c2nc(-c3cccs3)no2)CC1","inchiKey":"SJEVDMFUHCVNPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08471"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236484","canonicalSmiles":"O=C(O)c1cscn1","inchiKey":"HMVYYTRDXNKRBQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236484","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03422"]},"childChemblIds":["CHEMBL4126899","CHEMBL1601420"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237023","drugType":"Antibody","blackBoxWarning":false,"name":"DENOSUMAB","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prolia","Prolia, Ranmark Xgeva","Prolia, xgeva","Xgeva"],"synonyms":["AMG 162","AMG-162","Denosumab","QL-1206","QL1206","Ql1206","TK-006","TK006"],"crossReferences":{"DailyMed":["denosumab"],"DrugCentral":["4965"],"Wikipedia":["Denosumab"]},"count":32,"approvedIndications":["EFO_0009708","EFO_0004260","EFO_0003882","HP_0003072"],"linkedTargets":{"rows":["ENSG00000120659"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0003086","EFO_0003869","EFO_0000637","EFO_0001075","HP_0004349","EFO_0000756","EFO_0000681","EFO_0004274","MONDO_0007254","EFO_0000266","EFO_0003882","EFO_0000305","EFO_1000984","HP_0000938","EFO_1000318","EFO_0003931","EFO_1000786","MONDO_0008903","EFO_0000389","EFO_1000789","EFO_0000400","EFO_0009870","EFO_0004215","HP_0003072","EFO_0000685","EFO_0004260","Orphanet_666","EFO_0000384","EFO_0003060","MONDO_0008315","EFO_0009708","MONDO_0002171","EFO_0008519","EFO_0003854","EFO_0001378","MONDO_0024880","EFO_0003785","EFO_0007176"],"count":39},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 4 approved and 28 investigational indications."}
{"id":"CHEMBL1237119","canonicalSmiles":"CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O","inchiKey":"PAJMKGZZBBTTOY-ZFORQUDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREPROSTINIL","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Remodulin","Tyvaso"],"synonyms":["15-AU-81","15AU81","L-606","LRX -15","LRX-15","Treprostinil","Tresprostinil","UT-15"],"crossReferences":{"DailyMed":["treprostinil","treprostinil%20diolamine"],"drugbank":["DB00374"],"chEBI":["50861"]},"childChemblIds":["CHEMBL2107815"],"count":13,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","MONDO_0100130","EFO_1001103","EFO_0002687","EFO_0003875","EFO_0005207","MONDO_0001999","EFO_0000556","EFO_0003843","EFO_1001145","EFO_1001459","EFO_0000341","HP_0004419","EFO_0000717"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for recurrent thrombophlebitis and has 12 investigational indications."}
{"id":"CHEMBL1240977","canonicalSmiles":"CN1CCCN=C1/C=C/c1cccc(O)c1","inchiKey":"VRYKTHBAWRESFI-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXANTEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxantel"],"crossReferences":{"drugbank":["DB13670"]},"childChemblIds":["CHEMBL4303678"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1241951","canonicalSmiles":"COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1","inchiKey":"FWYSMLBETOMXAG-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETERMOVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prevymis"],"synonyms":["AIC 246","AIC-246","AIC246","Letermovir","MK-8228"],"crossReferences":{"DailyMed":["letermovir"],"drugbank":["DB12070"]},"count":2,"approvedIndications":["EFO_0000763","EFO_0001062"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for viral disease and cytomegalovirus infection."}
{"id":"CHEMBL1257024","canonicalSmiles":"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1.Cl","inchiKey":"AFBSBOBDKXETKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRENZEPINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL9967","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirenzepine Dihydrochloride"],"crossReferences":{"PubChem":["855667"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL126432","canonicalSmiles":"CCCSc1cc(OC)c(CCN)cc1OC","inchiKey":"OLEVEPDJOFPJTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126432","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2C-T-7"],"drugbank":["DB01458"]},"childChemblIds":["CHEMBL2359200"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276010","canonicalSmiles":"C=CCCCCCCCCC(=O)O","inchiKey":"FRPZMMHWLSIFAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNDECYLENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Undecylenic Acid","Undecylenic acid"],"crossReferences":{"PubChem":["144205210","144210701","170465527","29215364","68715"],"drugbank":["DB11117"],"chEBI":["35045"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276127","canonicalSmiles":"O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O","inchiKey":"CRDNMYFJWFXOCH-YPKPFQOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIRUBIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.I. 75790","Indirubin","NSC-105327"],"crossReferences":{"PubChem":["26756711","26756712","26756713"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1323699","canonicalSmiles":"CCCCC(CC)COC(=O)c1ccc(N(C)C)cc1","inchiKey":"WYWZRNAHINYAEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PADIMATE O","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arlatone uvb","Escalol 507","Spectraban 25","Spectraban 4","Spectraban ultra"],"synonyms":["Padimate o"],"crossReferences":{"PubChem":["144204564","144209619","144213879","170465499","17389329","26752790","49735490"],"drugbank":["DB11570"]},"count":1,"approvedIndications":["EFO_0003963"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for freckles."}
{"id":"CHEMBL13291","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21","inchiKey":"ROYOYTLGDLIGBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDIAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fludiazepam"],"crossReferences":{"Wikipedia":["Fludiazepam"],"drugbank":["DB01567"],"chEBI":["31618"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1334033","canonicalSmiles":"C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1.O=C(O)/C=C\\C(=O)O","inchiKey":"JDZOTSLZMQDFLG-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERHEXILINE MALEATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL75880","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," United Kingdom"],"classes":["Hepatotoxicity"," Neurotoxicity"],"year":1985},"tradeNames":["Pexid","Pexsig"],"synonyms":["Perhexiline maleate"],"crossReferences":{"PubChem":["144204948","170466435","26748746","56422147","855892"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. It was withdrawn in Spain and  United Kingdom initially in 1985 due to Hepatotoxicity and  Neurotoxicity."}
{"id":"CHEMBL1345380","canonicalSmiles":"CCCN(CCC)C(=O)C(CCC(=O)[O-])NC(=O)c1ccccc1.[Na+]","inchiKey":"UFMWGCINVOIJSO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1345380","maximumClinicalTrialPhase":0,"parentId":"CHEMBL316561","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855644"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1353","canonicalSmiles":"O=C([O-])O.[Na+]","inchiKey":"UIIMBOGNXHQVGW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BICARBONATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baking Soda","Monosodium Carbonate","Neut","Nurse harveys","S-bicarb","S-bicarb sf","Soda Mint","Sodibic","Sodium bicarbonate","Thamicarb"],"synonyms":["B1654","E-500(II)","E500","INS NO.500(II)","INS-500(II)","NSC-134031","Sodium Bicarbonate","Sodium bicarbonate"],"crossReferences":{"DailyMed":["sodium%20bicarbonate"],"DrugCentral":["4205"],"Wikipedia":["Sodium_bicarbonate"],"drugbank":["DB01390"],"chEBI":["32139"]},"count":25,"approvedIndications":["EFO_0003948","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for gastroesophageal reflux disease and pain and has 23 investigational indications."}
{"id":"CHEMBL1369407","canonicalSmiles":"CC(C)N=c1cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1","inchiKey":"WDQPAMHFFCXSNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1369407","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006615","49681815","855829"],"drugbank":["DB00845"],"chEBI":["3749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1409","canonicalSmiles":"COCCCC/C(=N\\OCCN)c1ccc(C(F)(F)F)cc1.O=C(O)/C=C\\C(=O)O","inchiKey":"LFMYNZPAVPMEGP-PIDGMYBPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUVOXAMINE MALEATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL814","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Faverin 100","Faverin 50","Floxyfral","Fluvoxamine maleate","Luvox","Luvox cr"],"synonyms":["DU-23000","DU23000","Fluvoxamine maleate"],"crossReferences":{"DailyMed":["fluvoxamine%20maleate"],"PubChem":["50106274","50106275","93576625"]},"count":2,"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0004262","MONDO_0002009","EFO_0004242"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL142438","canonicalSmiles":"N#N","inchiKey":"IJGRMHOSHXDMSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROGEN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-941","E941","INS NO.941","INS-941","Nitrogen","Nitrogen, liquid"],"crossReferences":{"drugbank":["DB09152"],"chEBI":["17997"]},"count":14,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 14 investigational indications."}
{"id":"CHEMBL1439","canonicalSmiles":"C[C@]1(Cn2ccnn2)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]","inchiKey":"RFMIKMMOLPNEDG-QVUDESDKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZOBACTAM SODIUM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL404","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tazocillin"],"synonyms":["CL 307,579","CL-307579","Tazobactam sodium","Tazobactam sodium salt"],"crossReferences":{"DailyMed":["tazobactam%20sodium"],"PubChem":["144205137","170465148"],"chEBI":["85192"]},"count":9,"approvedIndications":["EFO_0003106","EFO_0007149","EFO_1001388","EFO_0003103","EFO_1001459","EFO_0008588","EFO_0003035","EFO_0000544","EFO_1001312"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 9 approved indications."}
{"id":"CHEMBL1442934","canonicalSmiles":"CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO","inchiKey":"OTKJDMGTUTTYMP-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFINGOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SPC-100270","Safingol","Safingol hydrochloride"],"crossReferences":{"PubChem":["144204778","170466518","26754970","26754971"],"drugbank":["DB11924"]},"childChemblIds":["CHEMBL2107808"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1476022","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"IIVBFTNIGYRNQY-YQLZSBIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOMEGESTROL ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nomegestrol acetate","ORG 10486-0","ORG-10486-0","TX 066","TX-066"],"crossReferences":{"PubChem":["56463139"],"drugbank":["DB13981"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1488165","canonicalSmiles":"O=C1CC[C@@H](C(=O)N2CSC[C@H]2C(=O)O)N1","inchiKey":"UUTKICFRNVKFRG-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIDOTIMOD","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pidotimod"],"crossReferences":{"PubChem":["144205418","26719899","49648325"],"Wikipedia":["Pidotimod"],"drugbank":["DB11364"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL149752","canonicalSmiles":"CCCCCCCc1ccc(O)cc1","inchiKey":"KNDDEFBFJLKPFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Heptyl-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Heptyl-Phenol","4-Heptylphenol"],"crossReferences":{"PubChem":["144211865"],"drugbank":["DB03941"],"chEBI":["34438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL151445","canonicalSmiles":"OCC(O)CN1CCN(c2ccccc2)CC1","inchiKey":"PTVWPYVOOKLBCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROPROPIZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dropropizine","U.C.B.-1967","UCB 1967","UCB-1967"],"crossReferences":{"PubChem":["104171374","144204393","170466654","56422462"],"Wikipedia":["Dropropizine"],"drugbank":["DB13785"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1552","canonicalSmiles":"C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"GHCZAUBVMUEKKP-GYPHWSFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOCHENODEOXYCHOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glycochenodeoxycholate"],"crossReferences":{"drugbank":["DB02123"],"chEBI":["36274"]},"childChemblIds":["CHEMBL2028607"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1566956","canonicalSmiles":"COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC","inchiKey":"YSIITVVESCNIPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROXIPIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Troxipide"],"crossReferences":{"PubChem":["144206934","170465889","26719893"],"Wikipedia":["Troxipide"],"drugbank":["DB13419"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1593765","canonicalSmiles":"COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1.Cl.Cl","inchiKey":"HZVCEQMJXMUXJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1593765","maximumClinicalTrialPhase":0,"parentId":"CHEMBL142635","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50106810"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628227","canonicalSmiles":"CN(C)CCC=C1c2ccccc2COc2ccccc21","inchiKey":"ODQWQRRAPPTVAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXEPIN","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sinepin","Sinequan"],"synonyms":["Doxepin","P-3693A","Zonalon"],"crossReferences":{"DailyMed":["doxepin%20hydrochloride"],"PubChem":["174006603"],"TG-GATEs":["39"],"drugbank":["DB01142"],"chEBI":["4710"]},"childChemblIds":["CHEMBL1628234"],"count":8,"approvedIndications":["HP_0000989","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0002050","EFO_0000555","HP_0000726","MONDO_0007254","EFO_0003761","EFO_0005230","EFO_0003843","EFO_0004698","EFO_0000692","EFO_1001904"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for unipolar depression and pruritus and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL16370","canonicalSmiles":"ClCCCl","inchiKey":"WSLDOOZREJYCGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,2-DICHLOROETHANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2-Dichloro-Ethane","1,2-Dichloroethane","Dichloroethylene"],"crossReferences":{"PubChem":["144209664","17389930"],"Wikipedia":["1,2-Dichloroethane"],"drugbank":["DB03733"],"chEBI":["27789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697744","canonicalSmiles":"O=C(O)CSCC(=O)NC1CCSC1=O","inchiKey":"QGFORSXNKQLDNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERDOSTEINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Erdosteine"],"crossReferences":{"PubChem":["124896662","144206727","170465586"],"drugbank":["DB05057"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1705525","canonicalSmiles":"CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1","inchiKey":"KTXBOOWDLPUROC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICARAVEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicaraven"],"crossReferences":{"PubChem":["144205407","29216176"],"drugbank":["DB06397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL171679","canonicalSmiles":"COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O","inchiKey":"IAOZJIPTCAWIRG-QWRGUYRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARTAME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APM","Aspartame","E951","SC-18862"],"crossReferences":{"PubChem":["144204631","144205012","144213282","170466109","17390037","26752906","47193879"],"Wikipedia":["Aspartame"],"drugbank":["DB00168"],"chEBI":["2877"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1740513","canonicalSmiles":"CC(C)Nc1ncccn1","inchiKey":"FTCYIGBVOHNHCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAXONINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1984},"tradeNames":[],"synonyms":["Isaxonine"],"childChemblIds":["CHEMBL1697751"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1984 due to Hepatotoxicity."}
{"id":"CHEMBL1743757","canonicalSmiles":"CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@]1(C)O.Cl.Cl","inchiKey":"XENHXZMAOSTXGD-DSMKLBDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOPICITABINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL393820","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NM-283 DIHYDROCHLORIDE","NM283","Valopicitabine dihydrochloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1744033","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBCITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bismuth Subcitrate","Colloidal bismuth subcitrate","Tripotassium dicitratobismuthate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1753","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1","inchiKey":"KDLRVYVGXIQJDK-AWPVFWJPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antirobe","Cleocin","Cleocin T","Sobelin"],"synonyms":["Chlorodeoxylincomycin","Chlorolincomycin","Clindamycin","U-21,251","U-21251"],"crossReferences":{"DailyMed":["clindamycin%20hydrochloride"]},"childChemblIds":["CHEMBL1200588"],"count":19,"approvedIndications":["EFO_0000771","EFO_0000544","EFO_0003894","EFO_0003102","EFO_1001312"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 5 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL176467","canonicalSmiles":"CC1(c2ccc(Oc3ccccc3)cc2)C(=O)NC(=O)NC1=O","inchiKey":"RTBMLCLTYAPKIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL176467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03368"],"chEBI":["43179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL176602","canonicalSmiles":"CC(C)C[C@H](C(=O)NO)N(Cc1ccccc1)[P@](C)(=O)c1ccccc1","inchiKey":"KGUVBHLPMGERAT-NIYFSFCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL176602","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1774645","canonicalSmiles":"CNc1ccc(-c2nc3ccc([18F])cc3s2)cc1","inchiKey":"QLWFXLJVGCECSV-HUYCHCPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1774645","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1774642","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15457"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1795071","canonicalSmiles":"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O","inchiKey":"JFMWPOCYMYGEDM-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUXOLITINIB PHOSPHATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1789941","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jakafi"],"synonyms":["INCB-018424 PHOSPHATE","INCB-018424 SALT","INCB-18424 PHOSPHATE","INCB018424 PHOSPHATE","INCB018424 SALT","Ruxolitinib phosphate"],"crossReferences":{"DailyMed":["ruxolitinib%20phosphate"],"chEBI":["66917"]},"count":8,"approvedIndications":["EFO_0002430","EFO_0002429"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["EFO_1000253","EFO_0000466","EFO_1001958","EFO_0000220","EFO_0000222","EFO_0000305","EFO_0002429","EFO_0002430","EFO_0000339","EFO_0001068","EFO_0000095","MONDO_0024880","EFO_1000042","EFO_1000494"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for polycythemia vera and primary myelofibrosis and has 6 investigational indications."}
{"id":"CHEMBL1822916","canonicalSmiles":"CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21.Cl","inchiKey":"APFMVAHRFWBCDG-JUOYHRLASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECOPIPAM HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL298406","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ecopipam hydrochloride","SCH 39166"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908359","canonicalSmiles":"O=P([O-])([O-])F.[Na+].[Na+]","inchiKey":"BFDWBSRJQZPEEB-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM MONOFLUOROPHOSPHATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Extra-strength aim","Mono-tridin"],"synonyms":["NSC-248","Sodium fluorophosphate","Sodium monofluorophosphate"],"crossReferences":{"DrugCentral":["4252"],"drugbank":["DB09484"],"chEBI":["86431"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 3 investigational indications."}
{"id":"CHEMBL1909302","drugType":"Small molecule","blackBoxWarning":false,"name":"lambda","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2096647","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1915540","canonicalSmiles":"CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1","inchiKey":"ISBHYKVAFKTATD-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADRIFORANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adriforant","NVP-ZPL389-NX","PF-03893787","PF-3893787","Pf-03893787","ZPL-389","ZPL-389-NX","ZPL-3893787","ZPL389-NX"],"crossReferences":{"drugbank":["DB15027"]},"count":3,"linkedTargets":{"rows":["ENSG00000134489"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000676","EFO_0000274"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1921976","canonicalSmiles":"CNC(=O)c1ccc2cc([C@@]3(O)CCn4cncc43)ccc2c1","inchiKey":"OZPFIJIOIVJZMN-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORTERONEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Orteronel","TAK-700"],"crossReferences":{"Wikipedia":["Orteronel"],"drugbank":["DB12066"]},"count":4,"linkedTargets":{"rows":["ENSG00000148795"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","MONDO_0007254","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2051956","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1","inchiKey":"SVJMLYUFVDMUHP-MGBGTMOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXNIGULDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexniguldipine","niguldipine"],"crossReferences":{"drugbank":["DB14068"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2093879","canonicalSmiles":"[3H]C([3H])([3H])N([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1","inchiKey":"JTCAGRAKUAAYDY-MQWRLFSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2093879","maximumClinicalTrialPhase":0,"parentId":"CHEMBL561132","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103831","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1","inchiKey":"AKFJWRDCWYYTIG-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPROXCINOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-P900758XX","AZD-3582","AZD3582","HCT 3012","HCT-3012","Naproxcinod"],"crossReferences":{"drugbank":["DB06682"],"chEBI":["76254"]},"count":5,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0002506","EFO_1000786","EFO_0001421","EFO_1002048","EFO_0005755"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2103860","canonicalSmiles":"COC(=O)[C@H](c1ccccc1)N1CCC(c2ccc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)cc2)CC1","inchiKey":"WSYALRNYQFNNGP-HKBQPEDESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"USISTAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-16269110","JNJ16269110","R-256918","R256918","Usistapide"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103882","canonicalSmiles":"O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12","inchiKey":"UCEQXRCJXIVODC-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIVANTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARQ 197","ARQ-197","Arq-197","Tivantinib"],"crossReferences":{"drugbank":["DB12200"]},"count":16,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007576","EFO_0000305","EFO_0003060","EFO_0000311","EFO_0000640","MONDO_0001056","MONDO_0002691","EFO_1001480","EFO_0003860","EFO_0000770","EFO_0000182","EFO_0000702","EFO_0000673","EFO_0000514","EFO_0001378","EFO_0000181"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL2105435","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1","inchiKey":"JLRNKCZRCMIVKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CLY-503","Diclofibrate","Simfibrate"],"crossReferences":{"PubChem":["170466018"],"drugbank":["DB13433"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105883","canonicalSmiles":"C=COC=C","inchiKey":"QYKIQEUNHZKYBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINYL ETHER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vinyl ether"],"crossReferences":{"drugbank":["DB13690"],"chEBI":["81293"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL210593","canonicalSmiles":"Cc1cc(S(=O)(=O)N2CCC[C@H]2C(=O)O)c(N)cc1Cl","inchiKey":"OWYKAFABUYXQLE-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL210593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07273"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106059","canonicalSmiles":"C=CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AHMMSNQYOPMLSX-CNQKSJKFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOLDENONE UNDECYLENATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA-29038","Boldenone","Boldenone undecylenate"],"crossReferences":{"drugbank":["DB14639"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106184","canonicalSmiles":"C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@@]21C.[Na+]","inchiKey":"FKJIJBSJQSMPTI-CAOXKPNISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DEHYDROCHOLATE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL514446","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Decholin sodium"],"synonyms":["Dehydrocholate sodium","Sodium dehydrocholate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107339","canonicalSmiles":"CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\\C(=O)O","inchiKey":"RPUBHMMISKEXSR-MLCLTIQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESMIRTAZAPINE MALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1366933","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Esmirtazapine maleate","ORG 50081","ORG-50081","Org-50081"],"count":1,"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000102468","ENSG00000196639","ENSG00000150594","ENSG00000147246"],"count":6},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107380","canonicalSmiles":"CCOCCO[C@@H]1CC[C@@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\\C)[C@@H](OC)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC","inchiKey":"YYSFXUWWPNHNAZ-PKJQJFMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMIROLIMUS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Umirolimus"],"crossReferences":{"drugbank":["DB15527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107777","canonicalSmiles":"CCOc1ccc2c(c1)[C@]1(CC[C@H](CCN3CCOCC3)CC1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1OC","inchiKey":"CDSBFDCCJJDFCV-CKZSCMLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SATAVAPTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aquilda"],"synonyms":["SR 121463","SR 121463A","SR-121463","SR-121463A","SR121463B","SR121463F","Satavaptan","Sr121463"],"count":4,"linkedTargets":{"rows":["ENSG00000126895"],"count":1},"linkedDiseases":{"rows":["EFO_0001422","HP_0002902","EFO_1000982","HP_0001541"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107876","drugType":"Enzyme","blackBoxWarning":false,"name":"CONDOLIASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Condoliase","SI-6603"],"description":"Enzyme drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2107888","drugType":"Antibody","blackBoxWarning":false,"name":"TALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C21/AL-90","HU-901","TNX-901","Talizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108293","drugType":"Gene","blackBoxWarning":false,"name":"RIFERMINOGENE PECAPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Riferminogene pecaplasmid","XRP-0038","XRP0038"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108427","drugType":"Protein","blackBoxWarning":false,"name":"MENOTROPINS","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humegon","Menopur","Merional","Normegon","Pergonal","Pergonal low lh"],"synonyms":["FSH","Follicle stimulating hormone","Follotropin","HMG","Human follicle stimulating hormone","Menotrophin","Menotropins","Menotropins (fsh;lh)"],"crossReferences":{"DailyMed":["menotropins%20(fsh;lh)"]},"count":8,"linkedTargets":{"rows":["ENSG00000170820","ENSG00000138039"],"count":2},"linkedDiseases":{"rows":["EFO_0004248","MONDO_0002146","MONDO_0002259","EFO_0000545","EFO_0000279","EFO_0008560","EFO_0000660","Orphanet_478","MONDO_0018555","EFO_0002950"],"count":10},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 8 investigational indications."}
{"id":"CHEMBL2109452","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-4212","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-4212","MEDI4212","Medi-4212"],"count":2,"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000274","MONDO_0004784"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109586","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-780","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-780","Amg-780"],"count":1,"linkedTargets":{"rows":["ENSG00000091879","ENSG00000154188"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110652","canonicalSmiles":"CCn1c2c(c3ccccc31)CCSC2(C)CCN(C)C","inchiKey":"BRPOADLGOFPKKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANDAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tandamine"],"crossReferences":{"drugbank":["DB09192"]},"childChemblIds":["CHEMBL2104802"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111107","canonicalSmiles":"O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)C2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"WHRODDIHRRDWEW-ZWYCLXBASA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SUGAMMADEX","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Sugammadex"],"crossReferences":{"DailyMed":["sugammadex%20sodium"]},"childChemblIds":["CHEMBL2107374"],"count":8,"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 8 investigational indications."}
{"id":"CHEMBL211471","canonicalSmiles":"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.COS(=O)(=O)[O-]","inchiKey":"OSZNNLWOYWAHSS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOSTIGMINE METHYLSULFATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL278020","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bloxiverz","Neostigmine methylsulfate","Prostigmine","Robinul-neostig"],"synonyms":["NSC-93753","Neostigmine methyl sulfate","Neostigmine methylsulfate","Neostigmine metilsulfate"],"crossReferences":{"DailyMed":["neostigmine%20methylsulfate"],"PubChem":["56422780","855838"],"chEBI":["7516"]},"count":2,"approvedIndications":["EFO_0004991"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0004991","HP_0003270","HP_0025267","HP_0002315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for myasthenia gravis and has 1 investigational indication."}
{"id":"CHEMBL2146099","canonicalSmiles":"O=C([O-])Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)[O-])c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1.[Na+].[Na+]","inchiKey":"ZGEPTUZKSXWWAB-PNGDFCJYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMOSIAMOSE DISODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1215923","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bimosiamose disodium","TBC1269Z"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL22","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC","inchiKey":"IEDVJHCEMCRBQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ipral","Ledatrim","Monotrim","Proloprim","Proloprin","Syraprim","Tiempe","Trimethoprim","Trimogal","Trimopan","Trimpex","Trimpex 200","Triprimix 200"],"synonyms":["BW 56-72","BW-56-72","NIH-204","NSC-106568","Polytrim","Primsol","TCMDC-125538","Trimethoprim"],"crossReferences":{"DailyMed":["trimethoprim","trimethoprim%20hydrochloride","trimethoprim%20sulfate"],"PubChem":["104171255","11111923","11111924","11113621","124881732","144203842","144207355","170464633","17389524","174316130","26747124","26747125","26751820","50085866","50104512","50104513","85231275","85747719","857743","90340764"],"Wikipedia":["Trimethoprim"],"drugbank":["DB00440"],"chEBI":["45924"]},"childChemblIds":["CHEMBL2110367","CHEMBL2237501","CHEMBL1430611","CHEMBL2237502","CHEMBL1201080"],"count":27,"approvedIndications":["EFO_0007448","EFO_0000771","EFO_0003103","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 23 investigational indications."}
{"id":"CHEMBL240963","canonicalSmiles":"O=C1C=C(O)C(=O)c2ccccc21","inchiKey":"CSFWPUWCSPOLJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAWSONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Hydroxynaphthoquinone","Lawsone","NSC-8625"],"crossReferences":{"PubChem":["26749851","50107733"],"Wikipedia":["Lawsone"],"drugbank":["DB04744"],"chEBI":["44401"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL252556","canonicalSmiles":"COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O","inchiKey":"JGPMMRGNQUBGND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDEBENONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Raxone"],"synonyms":["Idebenone"],"crossReferences":{"PubChem":["144205417","170465611","174006221","26719872","29216196"],"Wikipedia":["Idebenone"],"chEBI":["31687"]},"count":6,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder and has 5 investigational indications."}
{"id":"CHEMBL258734","canonicalSmiles":"CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\\[C@@H]2C[C@@]2(C(=O)NS(=O)(=O)C2CC2)NC(=O)[C@@H]2C[C@@H](OC(=O)N3Cc4cccc(F)c4C3)CN2C1=O","inchiKey":"ZVTDLPBHTSMEJZ-JSZLBQEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANOPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danoprevir","R-05190591","R05190591","RO-5190591","RO5190591"],"crossReferences":{"drugbank":["DB11779"]},"childChemblIds":["CHEMBL2146090"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL259126","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CC[C@H](O)CC4=CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"VVUQRXPUVKXAIO-XFUVECHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01455"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259724","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"UJLXYODCHAELLY-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259724","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03103"],"chEBI":["18075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270271","canonicalSmiles":"CCC1COC(Cn2cncn2)(c2ccc(Cl)cc2Cl)O1","inchiKey":"DWRKFAJEBUWTQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETACONAZOLE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGA-64251","Etaconazole"],"crossReferences":{"PubChem":["144211885","29217946"],"chEBI":["4874"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL273101","canonicalSmiles":"Cc1c(Br)c(=O)oc2c(Br)c(O)ccc12","inchiKey":"MSOLROYRAHCJNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL273101","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24823436"],"drugbank":["DB07802"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL274654","canonicalSmiles":"Cc1[nH]c(/C=C2\\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O","inchiKey":"NHFDRBXTEDBWCZ-ZROIWOOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORANTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-702827","Orantinib","SU-6668","Su-6668","TSU-68"],"crossReferences":{"PubChem":["527809"],"drugbank":["DB12072"]},"count":10,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867","ENSG00000113721"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0002618","MONDO_0008903","EFO_0000182","MONDO_0007254","MONDO_0002367","EFO_0001378","MONDO_0008315","EFO_1001951"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL274826","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"AEMFNILZOJDQLW-QAGGRKNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTENEDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstenedione"],"crossReferences":{"PubChem":["144204444","144209467","144210896","170465907","17389251","17389252","26751578","29215020","50104208","85148334","855972"],"Wikipedia":["Androstenedione"],"drugbank":["DB01536"],"chEBI":["16422"]},"childChemblIds":["CHEMBL2311155"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275742","canonicalSmiles":"CC(C)NC[C@@H](O)COc1cccc2ccccc12","inchiKey":"AQHHHDLHHXJYJD-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPROPRANOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexpropranolol"],"crossReferences":{"PubChem":["104171303","11111608","11111609","11112324","11112325","11112326","11113604","11113728","124881054","124882253","144203986","170464682","26751915"],"drugbank":["DB03322"],"chEBI":["8736"]},"childChemblIds":["CHEMBL1358662"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL283196","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12","inchiKey":"VFMMPHCGEFXGIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHA-NAPHTHOFLAVONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7,8-Benzoflavone","Alpha-Naphthoflavone","Alpha-Naphtholflavone","Alpha-Naphtoflavone"],"crossReferences":{"PubChem":["11113127","124882822","26754187"],"Wikipedia":["Alpha-Naphthoflavone"],"drugbank":["DB07453"],"chEBI":["76995"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28333","canonicalSmiles":"CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"YLCXGBZIZBEVPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nobrium"],"synonyms":["Medazepam"],"crossReferences":{"PubChem":["144206658","26757942"],"Wikipedia":["Medazepam"],"drugbank":["DB13437"]},"childChemblIds":["CHEMBL2106842"],"count":1,"approvedIndications":["EFO_0005230"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anxiety."}
{"id":"CHEMBL284348","canonicalSmiles":"Nc1ccncc1","inchiKey":"NUKYPUAOHBNCPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DALFAMPRIDINE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","NSC-15041"],"crossReferences":{"DailyMed":["dalfampridine"],"PubChem":["104171097","11110683","11113806","124879040","124879042","136964060","144203616","144207991","170466526","26747141","26751980","26751983","50104658","8139900","90341267"],"Wikipedia":["4-Aminopyridine"],"drugbank":["DB06637"],"chEBI":["34385"]},"count":13,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000129159","ENSG00000168263","ENSG00000053918","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000135519","ENSG00000168418","ENSG00000158445","ENSG00000089558","ENSG00000177301","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["HP_0001257","EFO_0009602","EFO_0007405","HP_0002140","EFO_0003782","Orphanet_97","EFO_1000809","EFO_1001919","EFO_0003929","EFO_0004335","EFO_0009490","MONDO_0021553","EFO_0003885","HP_0000083","Orphanet_83419","EFO_0008520","EFO_0000712","EFO_0007292","EFO_1000632","EFO_0003918","EFO_0008522"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for multiple sclerosis and has 12 investigational indications."}
{"id":"CHEMBL294144","canonicalSmiles":"COc1cccc2c1CCC(=O)N2CCCN1CCN(c2cccc(Cl)c2)CC1","inchiKey":"TZZGTNZBLPCBIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL294144","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05422"]},"childChemblIds":["CHEMBL2115473","CHEMBL2115061"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL299233","canonicalSmiles":"CNCCCC1(c2ccccc2)OC(C)(C)c2ccccc21","inchiKey":"LJBBMCNHIUJBDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALOPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talopram"],"crossReferences":{"drugbank":["DB09190"]},"childChemblIds":["CHEMBL2105328"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30336","canonicalSmiles":"COc1cc(CC(C)N)cc(OC)c1OC","inchiKey":"WGTASENVNYJZBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL30336","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01516"]},"childChemblIds":["CHEMBL534688"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303960","canonicalSmiles":"COCc1cccc(C[C@H](O)/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2CCSCCCC(=O)OC)c1","inchiKey":"FBQUXLIJKPWCAO-AZIFJQEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVENPROST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONO-4819","Rivenprost"],"count":1,"linkedTargets":{"rows":["ENSG00000171522"],"count":1},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3137326","canonicalSmiles":"[2H]C([2H])([2H])Oc1cc2c(cc1OC([2H])([2H])[2H])C1CC(=O)C(CC(C)C)CN1CC2","inchiKey":"MKJIEFSOBYUXJB-LIJFRPJRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DUTETRABENAZINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL117785","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Austedo"],"synonyms":["Deutetrabenazine","Dutetrabenazine","SD-809"],"crossReferences":{"DailyMed":["deutetrabenazine"]},"count":6,"approvedIndications":["EFO_0004152"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004280","MONDO_0003441","EFO_0004895","EFO_1000632","EFO_0004152"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chorea and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL31634","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br","inchiKey":"ODZBBRURCPAEIQ-PIXDULNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIVUDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BVDU","Brivudine","Bromovinyldeoxyuridine","NSC-633770","RP-101","RP101"],"crossReferences":{"PubChem":["144204764","50105913"],"Wikipedia":["Brivudine"],"drugbank":["DB03312"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3187683","canonicalSmiles":"CCCCCC[C@@H](CCC)C(=O)O","inchiKey":"YCYMCMYLORLIJX-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARUNDIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arundic acid","MK-0724","MK0724","ONO-2506PO","Ono-2506po"],"crossReferences":{"PubChem":["144206875"],"drugbank":["DB05343"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3187812","canonicalSmiles":"CC(=O)S[C@H](C(=O)N[C@H]1Cc2ccccc2[C@H]2CCC[C@@H](C(=O)O)N2C1=O)C(C)C","inchiKey":"FXKFFTMLFPWYFH-RDGPPVDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILEPATRIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-7688","AVE7688","Ave7688","Ilepatril"],"crossReferences":{"PubChem":["144210558"],"drugbank":["DB06604"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL319516","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(P(=O)(O)O)c(P(=O)(O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"WCMLXBUNHNAMNH-UIOOFZCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL319516","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02336"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3234203","canonicalSmiles":"CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2.O=C(O)C(F)(F)F","inchiKey":"QUEFMGZAPMDQBZ-NQLNPJAESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3234203","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2105762","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3244648","canonicalSmiles":"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Na+].[Na+]","inchiKey":"DASQOOZCTWOQPA-GXKRWWSZSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOTREXATE SODIUM","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL34259","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abitrexate","Folex","Folex pfs","Methotrexate lpf","Methotrexate preservative free","Methotrexate sodium","Methotrexate sodium preservative free","Mexate","Mexate-aq","Mexate-aq preserved","Trexall","Xatmep"],"synonyms":["ADX-2191 SODIUM","Methotrexate disodium salt","Methotrexate sodium"],"crossReferences":{"DailyMed":["methotrexate%20sodium"],"chEBI":["50679"]},"count":1,"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["EFO_0000220"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3250771","canonicalSmiles":"O=S(=O)(O)O.[2H]c1c([2H])c([2H])c(C([2H])([2H])C(C)N)c([2H])c1[2H]","inchiKey":"SOFQDLYSFOWTJX-SGFNKLICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250771","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL330572","canonicalSmiles":"N=C(N)c1ccc(O)c(CN2CC[C@H](NS(=O)(=O)c3cc4ncccc4s3)C2=O)c1","inchiKey":"PQJGWYQPOHCEDO-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL330572","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL335315","canonicalSmiles":"CC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"IBONACLSSOLHFU-JAJWTYFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL335315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02320"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL340813","canonicalSmiles":"Oc1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1","inchiKey":"RFSDQDHHBKYQOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-6086","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-6086"],"crossReferences":{"drugbank":["DB08233"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3427435","canonicalSmiles":"O=C(O)CC[C@H](NP(=O)(O)OCCC[C@H](NC(=O)CC[C@H](NC(=O)CCCCCNC(=O)c1ccc(F)cc1)C(=O)O)C(=O)O)C(=O)O","inchiKey":"IZLOSIXADNUSCM-ACRUOGEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CTT-1057","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CTT1057","Ctt-1057","Ctt1057"],"crossReferences":{"drugbank":["DB14965"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3526992","canonicalSmiles":"CCO[14c]1[14cH][14cH][14c](Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)[14cH][14cH]1.O=C1CC[C@@H](C(=O)O)N1","inchiKey":"YHIUPZFKHZTLSH-FMUBFKMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526992","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1770248","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544564","canonicalSmiles":"C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"QGKQXZFZOIQFBI-XSWYFRFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3544564","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01479"],"chEBI":["79878"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544945","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-113945","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sar-113945"],"count":1,"linkedTargets":{"rows":["ENSG00000104365"],"count":1},"linkedDiseases":{"rows":["EFO_0002506"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545037","drugType":"Small molecule","blackBoxWarning":false,"name":"STX107","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Stx107"],"count":1,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["Orphanet_908"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545038","drugType":"Small molecule","blackBoxWarning":false,"name":"S-237648","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-237648"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545176","drugType":"Small molecule","blackBoxWarning":false,"name":"DB959","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Db959","T3D-959"],"count":1,"linkedTargets":{"rows":["ENSG00000112033","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545201","drugType":"Small molecule","blackBoxWarning":false,"name":"TA-5493","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ta-5493"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545306","drugType":"Unknown","blackBoxWarning":true,"name":"SULFUR HEXAFLUORIDE LIPID MICROSPHERE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lumason"],"synonyms":["Sulfur hexafluoride lipid microsphere","Sulfur hexafluoride lipid-type a microspheres"],"crossReferences":{"DailyMed":["sulfur%20hexafluoride%20lipid-type%20a%20microspheres"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2014 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL362148","canonicalSmiles":"NC1=NCCS1","inchiKey":"REGFWZVTTFGQOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Thiazolidin-(2E)-Ylideneamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiazolidin-(2E)-Ylideneamine"],"crossReferences":{"drugbank":["DB02335"],"chEBI":["40889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36633","canonicalSmiles":"NC(=O)CN1CC(O)CC1=O","inchiKey":"IHLAQQPQKRMGSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIRACETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP 21690E","CGP-21690E","GNF-PF-1005","Oxiracetam"],"crossReferences":{"PubChem":["50106803","85231168","90341150"],"Wikipedia":["Oxiracetam"],"drugbank":["DB13601"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707208","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS GLYCINE SULFATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fe-cap","Ferrocontin continus","Kelferon","Plesmet"],"synonyms":["Ferrous glycine sulfate","Ferrous glycine sulphate"],"count":1,"approvedIndications":["EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL3707367","canonicalSmiles":"OCCOc1ccc(Cl)cc1","inchiKey":"GEGSSUSEWOHAFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(4-CHLORPHENOXY)-ETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(4-chlorphenoxy)-ethanol"],"crossReferences":{"drugbank":["DB11368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707403","canonicalSmiles":"CCCCc1oc2ccc(C(=O)OC(C)C)cc2c1C(=O)c1ccc(CCCN(CCCC)CCCC)cc1","inchiKey":"ZCENNVQCOZQSGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELIVARONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Celivarone","K45001587E","SSR149744C","Ssr149744","UNII-K45001587E"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3764828","canonicalSmiles":"O=C([O-])c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O.[K+]","inchiKey":"XTRCGRNVMLSFPP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3764828","maximumClinicalTrialPhase":0,"parentId":"CHEMBL8","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL376756","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"RITKWYDZSSQNJI-INXYWQKQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"KISSPEPTIN-10","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kisspeptin-10"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL379000","canonicalSmiles":"COC(=O)C(Cc1ccccc1)(Cc1ccc(NS(=O)(=O)O)cc1)C(=O)OC","inchiKey":"SUACYXRSGYYBGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379000","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3813842","canonicalSmiles":"CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12","inchiKey":"LGWACEZVCMBSKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAXALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G02441729","GDC-0084","Paxalisib","Rg-7666"],"crossReferences":{"drugbank":["DB15186"]},"count":3,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0000519","EFO_1000158"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3813873","canonicalSmiles":"FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1","inchiKey":"JGWRKYUXBBNENE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PEXIDARTINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CML-261","PLX-3397","PLX3397","Pexidartinib","Plx-3397"],"crossReferences":{"DailyMed":["pexidartinib%20hydrochloride"],"drugbank":["DB12978"]},"childChemblIds":["CHEMBL3989973"],"count":15,"linkedTargets":{"rows":["ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000685","EFO_0000756","Orphanet_44890","MONDO_0007254","EFO_0000222","EFO_1001106","MONDO_0008315","MONDO_0002171","EFO_1000562","EFO_0003968","EFO_0001421","EFO_0000673","EFO_0000183","EFO_0000760","EFO_0000519","EFO_0002617"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3894518","canonicalSmiles":"CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1","inchiKey":"ZGRDYKFVDCFJCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8835","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8835","AZD8835","Azd 8835","Azd-8835","Azd8835"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3948043","canonicalSmiles":"COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl","inchiKey":"QAAOEMXHEWVIBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3948043","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545376","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3961037","canonicalSmiles":"CC(c1ccccc1)c1ccc(O)cc1O","inchiKey":"PQSXNIMHIHYFEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3961037","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14120"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989409","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](COP(=O)(O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)C(C)C","inchiKey":"XTAUIEMSNCLHEG-GGVFYUGVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FORIGERIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lupuzor"],"synonyms":["Forigerimod","IPP 201101","IPP-201101"],"childChemblIds":["CHEMBL3989801"],"count":1,"linkedTargets":{"rows":["ENSG00000109971"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989496","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)/C2=C\\F)c(=O)n1.O","inchiKey":"XPYQFIISZQCINN-QVXDJYSKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZACITABINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105467","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous","FMDC","MDL 101,731","Tezacitabine"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989655","canonicalSmiles":"O.O.O=P([O-])([O-])C(O)(Cn1ccnc1)P(=O)([O-])O.O=P([O-])([O-])C(O)(Cn1ccnc1)P(=O)([O-])O.O=P([O-])([O-])C(O)(Cn1ccnc1)P(=O)([O-])O.O=P([O-])([O-])C(O)(Cn1ccnc1)P(=O)([O-])O.O=P([O-])([O-])C(O)(Cn1ccnc1)P(=O)([O-])O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"HYMYRPXSMHJPGD-UHFFFAOYSA-A","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLEDRONATE TRISODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL924","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP 42446B","Zoledronate trisodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989794","canonicalSmiles":"CCOC(=O)[C@H](CCCc1ccccc1)C1(C(=O)N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O)CCCC1","inchiKey":"FVWPYVZWVOLAOP-DQEYMECFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAGLUTRIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daglutril","SLV-306","SLV306"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989819","canonicalSmiles":"CCCn1c(=O)c2nc([C@H]3C[C@H]4C[C@@H]3[C@@H]3O[C@H]43)[nH]c2n(CCC)c1=O","inchiKey":"OQCJPFYWFGUHIN-GJKBLCTNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAXIFYLLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BG9719","CVT-124","Naxifylline"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989923","canonicalSmiles":"O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Mg+2]","inchiKey":"MPAZKXHCZWDZDY-FFNUKLMVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN MAGNESIUM","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zypitamag"],"synonyms":["Pitavastatin magnesium"],"crossReferences":{"DailyMed":["pitavastatin%20magnesium"]},"count":2,"approvedIndications":["HP_0003119","EFO_0003774"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0003119","EFO_0003774"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for hyperlipidemia and abnormal circulating lipid concentration."}
{"id":"CHEMBL3989957","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F","inchiKey":"XGSRYNAQENZUAY-HKRGSHRKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BIVALIRUDIN TRIFLUOROACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103749","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Angiomax","Angiox"],"synonyms":["Bivalirudin trifluoroacetate"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404849","canonicalSmiles":"CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1","inchiKey":"BFCDFTHTSVTWOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULOCTIDIL","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," Germany"," France"],"classes":["Hepatotoxicity"],"year":1985},"tradeNames":[],"synonyms":["CP-556S","MJF 12637","Suloctidil"],"crossReferences":{"PubChem":["104171389","144204409","170466521","26748521"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157388","ENSG00000142408","ENSG00000165995","ENSG00000157445","ENSG00000100346","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000105605","ENSG00000167535","ENSG00000006116","ENSG00000007402","ENSG00000081248","ENSG00000102001","ENSG00000151062","ENSG00000006283","ENSG00000108878","ENSG00000141837","ENSG00000075429","ENSG00000182389","ENSG00000130433","ENSG00000196557","ENSG00000153956","ENSG00000067191"],"count":26},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for cardiovascular disease. It was withdrawn in Spain,  Germany and  France initially in 1985 due to Hepatotoxicity."}
{"id":"CHEMBL405862","canonicalSmiles":"CO[C@@H]1C[C@@H](C[C@H]2CC[C@H](C)[C@H]([C@@H](C)C(=O)O)O2)O[C@]2(O[C@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C)C[C@@H]4C)O3)C[C@H]2C)[C@@H]1C","inchiKey":"DANUORFCFTYTSZ-SJSJOXFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIGERICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nigericin"],"crossReferences":{"Wikipedia":["Nigericin"],"drugbank":["DB14056"],"chEBI":["7569"]},"childChemblIds":["CHEMBL2165715"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406254","canonicalSmiles":"O=c1[nH]c(Nc2ccccc2)nc2c1ncn2CCCCO","inchiKey":"JHBXNPBKSPYOFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406254","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406393","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]21C","inchiKey":"KXGVEGMKQFWNSR-LLQZFEROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYCHOLIC ACID","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kybella"],"synonyms":["ATX-101","DWJ-211","DWJ211","Deoxycholate","Deoxycholic acid","Desoxycholic acid","NSC-8797"],"crossReferences":{"DailyMed":["deoxycholic%20acid"],"PubChem":["47193711","74413"],"Wikipedia":["Deoxycholic_acid"],"drugbank":["DB03619"],"chEBI":["28834"]},"childChemblIds":["CHEMBL1365278","CHEMBL1884070"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 2 investigational indications."}
{"id":"CHEMBL416146","canonicalSmiles":"Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1","inchiKey":"MNJVRJDLRVPLFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETORICOXIB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arcoxia"],"synonyms":["Etoricoxib","L-791456","MK-0663"],"crossReferences":{"PubChem":["144205759","170465621","26758000"],"Wikipedia":["Etoricoxib"],"drugbank":["DB01628"],"chEBI":["6339"]},"count":15,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0005687","EFO_0003820","EFO_0000756","EFO_0004274","EFO_0010072","EFO_0003898","Orphanet_3389","EFO_0003843","MONDO_0008315","HP_0002315","EFO_0005755","EFO_0000546","EFO_0002506","EFO_0009582","EFO_0000649","EFO_0000764","EFO_0004616","HP_0003419","HP_0100607","EFO_1002012","EFO_1001434"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 14 investigational indications."}
{"id":"CHEMBL429","canonicalSmiles":"CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1","inchiKey":"SGUAFYQXFOLMHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LABETALOL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AH-5158A FREE BASE","Labetalol","Normodyne","Normozide","SCH-15719W FREE BASE","Trandate"],"crossReferences":{"DailyMed":["labetalol%20hydrochloride"],"PubChem":["90341718"],"TG-GATEs":["40"],"Wikipedia":["Labetalol"],"drugbank":["DB00598"],"chEBI":["6343"]},"childChemblIds":["CHEMBL1200323"],"count":10,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0002610","HP_0002140","EFO_0007486","EFO_0000712","EFO_0005669","EFO_0003768","EFO_0000319","MONDO_0001641","EFO_0000668","EFO_0005672","MONDO_0024664","EFO_0000537","EFO_0005251"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for cardiovascular disease and has 9 investigational indications."}
{"id":"CHEMBL4297263","drugType":"Small molecule","blackBoxWarning":false,"name":"AROPLATIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aroplatin"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297264","canonicalSmiles":"C1=Cc2ccccc2NN=C1","inchiKey":"SVUOLADPCWQTTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZODIAZEPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzodiazepine"],"crossReferences":{"drugbank":["DB12537"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297276","canonicalSmiles":"CC1=Nc2ccc(Cl)cc2S(=O)(=O)[N-]1.C[N+](C)(C)CCO","inchiKey":"YLLWQNAEYILHLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZOXIDE CHOLINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL181","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diazoxide choline"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297297","canonicalSmiles":"CCCCCCCOC(=O)NC1=NC(=O)N([C@H]2C[C@H](O)[C@@H](CO)O2)CN1","inchiKey":"SZWIAFVYPPMZML-YNEHKIRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KP-1461","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kp-1461"],"crossReferences":{"drugbank":["DB05644"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297423","canonicalSmiles":"Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCN1CCN(C)CC1)c1nnc(C)n1-2","inchiKey":"PKQXLRYFPSZKDU-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-6870810","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-JQ35","BET INHIBITOR TEN-010","RO6870810","Rg 6146","Ro-6870810","Ro6870810"],"crossReferences":{"drugbank":["DB15151"]},"count":4,"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0044889","EFO_0000222","EFO_0001378"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297669","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCCCCCCCCCCCCCCCC","inchiKey":"TZCPCKNHXULUIY-RGULYWFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHATIDYL SERINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphatidyl serine","Phosphatidylserine"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297709","drugType":"Unknown","blackBoxWarning":false,"name":"BMX-010","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEOL-10113","BMX-010","Bmx-010"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297867","drugType":"Protein","blackBoxWarning":false,"name":"EFMITERMANT ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACE-083","Ace-083","Efmitermant alfa"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297932","drugType":"Unknown","blackBoxWarning":false,"name":"DAS-181","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Das-181","Das181"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298009","drugType":"Antibody","blackBoxWarning":false,"name":"IERAMILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ieramilimab","LAG-525","LAG525","Lag 525","Lag525"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298196","drugType":"Small molecule","blackBoxWarning":false,"name":"VEVERIMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRC-101","TRC101","Veverimer"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298201","drugType":"Gene","blackBoxWarning":false,"name":"SIMOLADAGENE AUTOTEMCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OTL-101","Simoladagene autotemcel"],"count":1,"description":"Gene drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL437027","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(N)=O","inchiKey":"QXZBMSIDSOZZHK-DOPDSADYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BOMBESIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bombesin"],"crossReferences":{"Wikipedia":["Bombesin"],"drugbank":["DB11724"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL446036","canonicalSmiles":"O=CCC=O","inchiKey":"WSMYVTOQOOLQHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALONALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Malondialdehyde"],"crossReferences":{"drugbank":["DB03057"],"chEBI":["566274"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455946","canonicalSmiles":"NS(=O)(=O)c1ccc(NC(=O)c2n[nH]c3ccccc23)cc1","inchiKey":"MNHPHKFLWAPNOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455946","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08133"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458767","canonicalSmiles":"CCOP(=O)(OCC)C(=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)P(=O)(OCC)OCC","inchiKey":"YQLJDECYQDRSBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR-12813","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-12813"],"crossReferences":{"PubChem":["29217646"],"drugbank":["DB04466"],"chEBI":["77317"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594301","canonicalSmiles":"COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1","inchiKey":"QMTKNJZIWGTNTE-LMOVPXPDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"REMIMAZOLAM BESYLATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297526","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Byfavo"],"synonyms":["BIPRAZINE PF","CNS 7056 besylate","CNS 7056B","GW502056X","ONO-2745BS","ONO-IN-251","RF10007","Remimazolam besylate","SP148.5"],"crossReferences":{"DailyMed":["remimazolam%20besylate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4594466","drugType":"Unknown","blackBoxWarning":false,"name":"BIO89-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIO89-100","Bio89-100","TEV-47948"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594522","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-404","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 404","AMG-404","Amg 404","Amg-404"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL462605","canonicalSmiles":"Clc1ccc(CCCOCCCN2CCCCC2)cc1","inchiKey":"NNACHAUCXXVJSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITOLISANT","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Wakix","Wakix, europe"],"synonyms":["BF-2.649","BF-2649","BF2.649","Bf2.649","HBS-101","Pitolisant","Tiprolisant"],"crossReferences":{"DailyMed":["pitolisant%20hydrochloride"],"Wikipedia":["Pitolisant"],"drugbank":["DB11642"]},"childChemblIds":["CHEMBL4164059"],"count":8,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0003086","EFO_0005246","Orphanet_739","EFO_0003890","EFO_0002508","EFO_0000692","EFO_0000614","EFO_0003829"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 8 investigational indications."}
{"id":"CHEMBL479527","canonicalSmiles":"CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC","inchiKey":"CMSGWTNRGKRWGS-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TORCETRAPIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-529,414","CP-529414","Torcetrapib"],"crossReferences":{"Wikipedia":["Torcetrapib"],"drugbank":["DB06281"],"chEBI":["49203"]},"count":4,"linkedTargets":{"rows":["ENSG00000087237"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","HP_0003124","Orphanet_412","EFO_0001645","Orphanet_79211","EFO_0003774","EFO_0004911","Orphanet_413","Orphanet_309005"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL48396","canonicalSmiles":"Nc1ccc(S(=O)(=O)c2ccc(NCC(=O)O)cc2)cc1","inchiKey":"FKKUMFTYSTZUJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEDIASULFONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-158324"],"crossReferences":{"Wikipedia":["Acediasulfone"],"drugbank":["DB08926"]},"childChemblIds":["CHEMBL2105931"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497","canonicalSmiles":"Oc1c(I)cc(Cl)c2cccnc12","inchiKey":"QCDFBFJGMNKBDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIOQUINOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"," Japan"],"classes":["Neurotoxicity"],"year":1973},"tradeNames":["Domeform-hc","Oralcer","Quin-o-creme","Vioform"],"synonyms":["4-stearylamino-phenyl-trimethylam. metilsulf.","Clioquinol","Iodochlorhydroxyquin","NSC-3531","NSC-74938"],"crossReferences":{"PubChem":["104171297","11112285","124882179","124882180","144203967","144207489","170465019","17389542","24715134","26746922","85148761","855601"],"Wikipedia":["Clioquinol"],"drugbank":["DB04815"],"chEBI":["74460"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 7 investigational indications. It was withdrawn in United Kingdom,  United States,  Germany,  France and  Japan initially in 1973 due to Neurotoxicity."}
{"id":"CHEMBL516357","canonicalSmiles":"Nc1ncnc2c1nc(NCc1ccc(Cl)c(Cl)c1)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"VBJKVZXRYLCYGQ-XNIJJKJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL516357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07045"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL52564","canonicalSmiles":"O=C(O)/C=C/c1ccccc1O","inchiKey":"PMOWTIHVNWZYFI-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O-COUMARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E)-2-Hydroxycinnamic Acid","(E)-Coumarinic Acid","2-Hydroxycinnamic Acid","3-(2-Hydroxyphenyl)Acrylic Acid","O-Coumaric Acid"],"crossReferences":{"drugbank":["DB01650"],"chEBI":["18125"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL53292","canonicalSmiles":"Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1","inchiKey":"YYUAYBYLJSNDCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXICAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," Germany"," France"],"classes":["Dermatological toxicity"],"year":1983},"tradeNames":["Maxicam"],"synonyms":["Isoxicam","W 8495"],"crossReferences":{"PubChem":["11112741","144204185","170466334","26747065","855966"],"drugbank":["DB08942"],"chEBI":["76163"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Spain,  Germany and  France initially in 1983 due to Dermatological toxicity."}
{"id":"CHEMBL539","canonicalSmiles":"CC(=O)O","inchiKey":"QTBSBXVTEAMEQO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetasol","Acetic acid","Aci-jel","Earcalm","Orlex","Vosol"],"synonyms":["Acetic Acid","Acetic Acid, Glacial","Acetic acid","Acetic acid, glacial","E-260","E260","FEMA NO. 2006","Glacial acetic acid","INS NO.260","INS-260","NSC-111201","NSC-112209","NSC-115870","NSC-127175","NSC-132953","NSC-406306"],"crossReferences":{"DailyMed":["acetic%20acid,%20glacial"],"PubChem":["144211770"],"Wikipedia":["Acetic_acid"],"drugbank":["DB03166"],"chEBI":["15366"]},"childChemblIds":["CHEMBL4297336"],"count":2,"approvedIndications":["MP_0001845"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for inflammation and has 1 investigational indication."}
{"id":"CHEMBL545437","canonicalSmiles":"CCOC(=O)COc1ccc2c(c1)C[C@@H](NC[C@H](O)c1cccc(Cl)c1)CC2.Cl","inchiKey":"NQIZCDQCNYCVAS-RQBPZYBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIBEGRON HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1193948","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amibegron hydrochloride","SR-58611A","SR58611A","Sr-58611a"],"crossReferences":{"Wikipedia":["Amibegron"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL56475","canonicalSmiles":"Oc1ccc(I)cc1","inchiKey":"VSMDINRNYYEDRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Iodo-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Iodo-Phenol","4-Iodophenol"],"crossReferences":{"PubChem":["251919907"],"drugbank":["DB03002"],"chEBI":["43521"]},"childChemblIds":["CHEMBL3343677"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL575","canonicalSmiles":"COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"RJQXTJLFIWVMTO-TYNCELHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHICILLIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methicillin","Meticillin","Staphcillin"],"crossReferences":{"Wikipedia":["Meticillin"],"drugbank":["DB01603"],"chEBI":["6827"]},"childChemblIds":["CHEMBL1164","CHEMBL3181832"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL582887","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2OP(=O)(O)O)c(=O)n1","inchiKey":"YQUAKORMLHPSLZ-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL582887","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03765"],"chEBI":["28507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL599872","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1","inchiKey":"HPAPGONEMPZXMM-ONAXAZCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VANIPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7009","Vaniprevir"],"crossReferences":{"Wikipedia":["Vaniprevir"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL618","canonicalSmiles":"O=C(O)c1ccc(Cl)cc1","inchiKey":"XRHGYUZYPHTUJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-CHLORO-BENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Chlorobenzoic Acid"],"crossReferences":{"PubChem":["144214023","17388796","56436653"],"drugbank":["DB03728"],"chEBI":["30747"]},"childChemblIds":["CHEMBL1762652"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6259","canonicalSmiles":"CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1","inchiKey":"NOCJXYPHIIZEHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Difloxacin"],"crossReferences":{"PubChem":["29218066"],"Wikipedia":["Difloxacin"],"drugbank":["DB11511"],"chEBI":["4537"]},"childChemblIds":["CHEMBL542414"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6273","canonicalSmiles":"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1","inchiKey":"XBJBPGROQZJDOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLEROXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Megalone"],"synonyms":["AM-833","Fleroxacin","RO 23-6240/000","Ro-236240"],"crossReferences":{"PubChem":["144206106","170466056","26719809","50112812"],"Wikipedia":["Fleroxacin"],"drugbank":["DB04576"],"chEBI":["31810"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL65","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1","inchiKey":"VSJKWCGYPAHWDS-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMPTOTHECIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-94600"],"crossReferences":{"PubChem":["11111011","11112910","11113913","124882713","124882714","26732559","26747153","26747154","26747155","399733","50104726","50104727","50123248","85231337","90340668"],"Wikipedia":["Camptothecin"],"drugbank":["DB04690"],"chEBI":["27656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL651","canonicalSmiles":"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"USSIQXCVUWKGNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHADONE","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amidone","Dolophine","Heptadon","IDS-NM-002","Methadone","Methadose","Phy","Physeptone","Symoron","Westadone"],"crossReferences":{"DailyMed":["methadone%20hydrochloride"],"Wikipedia":["Methadone"],"drugbank":["DB00333"],"chEBI":["6807"]},"childChemblIds":["CHEMBL1200825"],"count":13,"approvedIndications":["EFO_0003890","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0004240","MONDO_0000726","EFO_0002610","HP_0012532","EFO_0000180","EFO_0010702","EFO_0003843","EFO_0000311","EFO_0004220","EFO_0003890","EFO_0000764","HP_0004308","EFO_0004273","EFO_0006510","HP_0003419","EFO_0005611","EFO_0003047","EFO_0003917","EFO_0005799","HP_0008419"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and is indicated for pain and drug dependence and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL69863","canonicalSmiles":"Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1","inchiKey":"CDRPUGZCRXZLFL-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICEATANNOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-365798"],"crossReferences":{"PubChem":["26753619","26753620","29215167","466622","50106772","50106773","50106774","56463614","90341169"],"drugbank":["DB08399"],"chEBI":["28814"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL778","canonicalSmiles":"Cc1cccc([C@H](C)c2c[nH]cn2)c1C","inchiKey":"CUHVIMMYOGQXCV-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMEDETOMIDINE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Precedex"],"synonyms":["Dexmedetomidine","MPV-1440"],"crossReferences":{"DailyMed":["dexmedetomidine%20hydrochloride"],"PubChem":["11114268"],"Wikipedia":["Dexmedetomidine"],"drugbank":["DB00633"],"chEBI":["4466"]},"childChemblIds":["CHEMBL2106195"],"count":50,"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003777","EFO_0002610","EFO_0004777","EFO_0007486","EFO_0009386","HP_0012735","EFO_0000275","MONDO_0002009","EFO_0000249","HP_0000175","EFO_1000800","EFO_0005773","EFO_0004698","HP_0100543","EFO_0003931","EFO_0002506","EFO_0003870","MONDO_0008903","MONDO_0021666","EFO_1000632","EFO_0000253","EFO_0000400","EFO_0000692","EFO_0009686","HP_0000360","MONDO_0005149","EFO_0003756","EFO_0001074","HP_0012532","EFO_0005578","EFO_0002687","HP_0001919","EFO_0002508","EFO_0005323","EFO_0003758","EFO_0009516","EFO_0000546","MP_0001914","MP_0001845","HP_0100806","MONDO_0100096","MONDO_0001208","HP_0002045","EFO_0003957","EFO_0004888","HP_0001336","Orphanet_1478","EFO_0000516","EFO_0000668","EFO_0004337","EFO_0003086","EFO_0001059","HP_0000303","EFO_0006834","EFO_0000278","EFO_1001905","EFO_1001454","EFO_0008507","MONDO_0007254","EFO_0009267","EFO_0008568","EFO_1002048","EFO_0002950","MONDO_0001056","EFO_0000474","EFO_0003959","EFO_0009514","HP_0030834","MONDO_0005299","EFO_0002460","EFO_0005230","EFO_0000239","EFO_0000616","EFO_0005774","HP_0001337","HP_0001662","MONDO_0021204","EFO_0004329","EFO_0001645","EFO_0005207","EFO_0000677","HP_0011110","EFO_1001884","EFO_0003818","EFO_0001073","EFO_0003843","HP_0002315","EFO_0002615","EFO_0000537","HP_0000713","EFO_0000311","HP_0001082","EFO_0003890","EFO_0000713","EFO_0010282","EFO_0004273","EFO_0005611","MONDO_0043510","EFO_0003918","GO_0035483","EFO_0003833","EFO_0005411","EFO_0004282","EFO_0004264"],"count":105},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 50 investigational indications."}
{"id":"CHEMBL880","canonicalSmiles":"CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O","inchiKey":"GGXKWVWZWMLJEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMCICLOVIR","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Famciclovir","Famvir"],"synonyms":["BRL-42810","Famciclovir","Famvir"],"crossReferences":{"DailyMed":["famciclovir"],"PubChem":["170464774","174006796","26719883","26748972"],"Wikipedia":["Famciclovir"],"drugbank":["DB00426"],"chEBI":["4974"]},"count":6,"approvedIndications":["EFO_1001347","EFO_0007282","EFO_0006510","EFO_1001888","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL92401","canonicalSmiles":"CC(C)NNC(=O)c1ccncc1","inchiKey":"NYMGNSNKLVNMIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRONIAZID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marsilid"],"synonyms":["Iproniazid","Iproniazide"],"crossReferences":{"PubChem":["11111333","11111334","50111104","90341605"],"TG-GATEs":["62"],"Wikipedia":["Iproniazid"],"drugbank":["DB04818"],"chEBI":["5958"]},"childChemblIds":["CHEMBL1256361","CHEMBL1534878"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL977","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O","inchiKey":"VWQWXZAWFPZJDA-CGVGKPPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE HEMISUCCINATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocortisone Hemisuccinate","Hydrocortisone succinate","NSC-7576"],"crossReferences":{"DailyMed":["hydrocortisone%20sodium%20succinate"],"PubChem":["56422426","855704"],"drugbank":["DB14545"],"chEBI":["31677"]},"childChemblIds":["CHEMBL3989663","CHEMBL1200495"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0006834","EFO_0000220","EFO_0000403","MONDO_0000870","HP_0004798","EFO_0000565","EFO_0000309","EFO_0003032","EFO_0000270","EFO_1001936","EFO_1001947","EFO_0009552","MONDO_0020743","EFO_0005752"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955."}
